Advertisement
NxStage's investor presentation is scheduled for Monday, October 6th at2:30 p.m. ET. To listen to the audio webcast of the presentation during theevent, please visit: http://www.nxstage.com and click on 'InvestorInformation.' A replay will be available for 30 days immediately following thelive presentation.
Advertisement
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,headquartered in Lawrence, Massachusetts, USA, that develops, manufactures andmarkets innovative products for the treatment of end-stage renal disease, orESRD, and acute kidney failure. For more information on NxStage and itsproducts, please visit the company's website at http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. All statements containedin this release that are not clearly historical in nature are forward-looking,and the words "anticipate," "believe," "expect," "estimate," "plan," andsimilar expressions are generally intended to identify forward-lookingstatements. Examples of these forward-looking statements include statements asto Mr. Burbank's and Mr. Brown's plans to present at the JMP SecuritiesHealthcare Focus Conference. NxStage specifically disclaims any obligation toupdate these forward-looking statements. These forward-looking statementsshould not be relied upon as representing NxStage's expectations or beliefs asof any date subsequent to the date of this press release.Contact: Kristen K. Sheppard, Esq. Investor Relations [email protected]
SOURCE NxStage Medical, Inc.
